Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00607529 · ClinicalTrials.gov registry record
Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 99
- Enrollment target
NCT00607529: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00607529 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 99 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00607529 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
This study is being done to see if the Nova Creatinine Meter can give a correct measure of creatinine (a blood test used to measure kidney function) when the blood is taken from a capillary (smallest type of blood vessels). The Nova Creatinine Meter is a hand held device that can be used in a clinic to measure creatinine in about 50 seconds. Current laboratory creatinine testing can take up to an hour. Since chemotherapy patients need to have their creatinine measured prior to treatment, this meter could make testing easier and faster.
Interventions
- OTHER hand-held POC creatinine analyzer-blood test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-05 |
What the finished NCT00607529 record still lists
NCT00607529 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 99 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which hand-held POC creatinine analyzer-blood test is the first listed.
NCT00607529 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00607529 about?
NCT00607529 is a clinical study titled "Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device". This study is being done to see if the Nova Creatinine Meter can give a correct measure of creatinine (a blood test used to measure kidney function) when the blood is taken from a capillary (smallest type of blood vessels). The Nova Creatinine Meter is a hand held device that can be used in a clinic...
What is the current status of trial NCT00607529?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2007-08. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00607529?
The interventions under investigation include: hand-held POC creatinine analyzer-blood test (OTHER).
Who is sponsoring clinical trial NCT00607529?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia